Neurology Research International / 2012 / Article / Fig 1

Clinical Study

A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression

Figure 1

Levels of tau in CSF of patients in active arm versus placebo arm at baseline and after six months of therapy. (*Significant difference in levels of tau at baseline between the two groups, P = 0.02 by Mann-Whitney t-test). Error bars denote standard deviation.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.